Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 202418
Company: AUROBINDO PHARMA LTD
Company: AUROBINDO PHARMA LTD
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| LAMIVUDINE AND ZIDOVUDINE | LAMIVUDINE; ZIDOVUDINE | 150MG;300MG | TABLET;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 05/15/2012 | ORIG-1 | Approval |
Label is not available on this site. |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 07/22/2019 | SUPPL-10 | Labeling-Package Insert |
Label is not available on this site. |
||
| 07/22/2019 | SUPPL-8 | Labeling-Package Insert |
Label is not available on this site. |
||
| 07/22/2019 | SUPPL-7 | Labeling-Package Insert |
Label is not available on this site. |
||
| 07/22/2019 | SUPPL-6 | Labeling-Package Insert, Labeling-Medication Guide |
Label is not available on this site. |
||
| 07/22/2019 | SUPPL-4 | Labeling-Package Insert |
Label is not available on this site. |